HIV-1 envelope glycoprotein (Env), a gp120–gp41 trimer, undergoes coordinated conformational changes that drive membrane fusion and allow immune evasion by transiently concealing ...
In the race of innovative drug R&D, whether for antibodies, peptides, or novel binding proteins, the efficiency of early-stage molecule discovery is always the key factor determining project success ...
Cloud-Clone leverages its expertise in biological reagents, animal models, and primary cells to support global ...
Lunit (KRX:328130), a leading provider of AI for cancer diagnostics and precision oncology, presented six studies at the American Association for Cancer Research (AACR) Annual Meeting 2026, taking ...
These advances, still under investigation, hold the promise of revolutionizing healthcare for future colorectal cancer ...
African swine fever (ASF) is a highly transmissible and often fatal disease affecting domestic and wild suids, with profound consequences for global pork ...
‘Amyloid-beta-targeting monoclonal antibodies for people with mild cognitive impairment or mild dementia due to Alzheimer’s disease’ was published in the Cochrane Database of Systematic Reviews at ...
How do astronauts track sleep? A new study introduces a smartphone-based melatonin test that monitors circadian rhythms in ...
The wave-shaped chart Ratul Chowdhury pulls up on a computer monitor in his office captures the evolutionary cat-and-mouse ...
Most cases linked to Korangi and Malir; study stresses immediate wound care and timely post-exposure treatment to prevent ...
Clinical trial readout (Primary endpoint) expected in June 2026 Plans to advance RAD 101 into U.S. Phase 3 pivotal trial SYDNEY, April 16, 2026 (GLOBE NEWSWIRE) -- Radiopharm Theranostics (ASX:RAD, ...
Synthetic biologists were tantalized by the idea of making mirror images of microbes. Then things got complicated.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results